Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

It Is Time to Address the Crisis in the Pharmacotherapy of Posttraumatic Stress Disorder: A Consensus Statement of the PTSD Psychopharmacology Working Group
John H. Krystal, Lori L. Davis, Thomas C. Neylan, et al.
Biological Psychiatry (2017) Vol. 82, Iss. 7, pp. e51-e59
Open Access | Times Cited: 228

Showing 1-25 of 228 citing articles:

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial
Michael C. Mithoefer, Ann T. Mithoefer, Allison A. Feduccia, et al.
The Lancet Psychiatry (2018) Vol. 5, Iss. 6, pp. 486-497
Closed Access | Times Cited: 386
Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits
Kerry J. Ressler, Sabina Berretta, Vadim Y. Bolshakov, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 5, pp. 273-288
Open Access | Times Cited: 251
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 206
3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial
Marcela Ot’alora G., Jim Grigsby, Bruce Poulter, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 12, pp. 1295-1307
Open Access | Times Cited: 191
Prefrontal cortex, amygdala, and threat processing: implications for PTSD
M. Alexandra Kredlow, Robert J. Fenster, Emma Laurent, et al.
Neuropsychopharmacology (2021) Vol. 47, Iss. 1, pp. 247-259
Open Access | Times Cited: 190
Reviewing the Potential of Psychedelics for the Treatment of PTSD
Erwin Krediet, Tijmen Bostoen, Joost J. Breeksema, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 23, Iss. 6, pp. 385-400
Open Access | Times Cited: 189
Elevated Anandamide, Enhanced Recall of Fear Extinction, and Attenuated Stress Responses Following Inhibition of Fatty Acid Amide Hydrolase: A Randomized, Controlled Experimental Medicine Trial
Leah M. Mayo, Anna Asratian, Johan Lindé, et al.
Biological Psychiatry (2019) Vol. 87, Iss. 6, pp. 538-547
Open Access | Times Cited: 183
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
Adriana Feder, Sara Costi, Sarah Rutter, et al.
American Journal of Psychiatry (2021) Vol. 178, Iss. 2, pp. 193-202
Closed Access | Times Cited: 172
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches
Marta Peciña, Jordan F. Karp, Sanjay J. Mathew, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 4, pp. 576-587
Open Access | Times Cited: 166
Sleep disturbance in PTSD and other anxiety-related disorders: an updated review of clinical features, physiological characteristics, and psychological and neurobiological mechanisms
Anne Richards, Jennifer C. Kanady, Thomas C. Neylan
Neuropsychopharmacology (2019) Vol. 45, Iss. 1, pp. 55-73
Open Access | Times Cited: 155
Shared mechanisms across the major psychiatric and neurodegenerative diseases
Thomas S. Wingo, Yue Liu, Ekaterina S. Gerasimov, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 116
The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder
Chadi G. Abdallah, Lynnette A. Averill, Teddy J. Akiki, et al.
The Annual Review of Pharmacology and Toxicology (2018) Vol. 59, Iss. 1, pp. 171-189
Open Access | Times Cited: 150
Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice
Leah M. Mayo, Anna Asratian, Johan Lindé, et al.
Molecular Psychiatry (2018) Vol. 25, Iss. 5, pp. 993-1005
Closed Access | Times Cited: 130
PTSD in women is associated with a block in conversion of progesterone to the GABAergic neurosteroids allopregnanolone and pregnanolone measured in plasma
Suzanne L. Pineles, Yael I. Nillni, Graziano Pinna, et al.
Psychoneuroendocrinology (2018) Vol. 93, pp. 133-141
Closed Access | Times Cited: 103
Factors associated with completing evidence-based psychotherapy for PTSD among veterans in a national healthcare system
Shira Maguen, Yongmei Li, Erin Madden, et al.
Psychiatry Research (2019) Vol. 274, pp. 112-128
Open Access | Times Cited: 99
Microglial cell hyper-ramification and neuronal dendritic spine loss in the hippocampus and medial prefrontal cortex in a mouse model of PTSD
Kristie Leigh Smith, Mustafa S. Kassem, David J. Clarke, et al.
Brain Behavior and Immunity (2019) Vol. 80, pp. 889-899
Closed Access | Times Cited: 96
Stress-induced blood brain barrier disruption: Molecular mechanisms and signaling pathways
Menizibeya O. Welcome, Nikos E. Mastorakis
Pharmacological Research (2020) Vol. 157, pp. 104769-104769
Closed Access | Times Cited: 93
Multiple memory systems, multiple time points: how science can inform treatment to control the expression of unwanted emotional memories
Renée M. Visser, Alex Lau‐Zhu, Richard N. Henson, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2018) Vol. 373, Iss. 1742, pp. 20170209-20170209
Open Access | Times Cited: 85
Attention to threat in posttraumatic stress disorder as indexed by eye-tracking indices: a systematic review
Amit Lazarov, Benjamin Suarez‐Jimenez, Amanda J. F. Tamman, et al.
Psychological Medicine (2018) Vol. 49, Iss. 5, pp. 705-726
Open Access | Times Cited: 85
PTSD is associated with neuroimmune suppression: evidence from PET imaging and postmortem transcriptomic studies
Shivani Bhatt, Ansel T. Hillmer, Matthew J. Girgenti, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 78
Real-world stress resilience is associated with the responsivity of the locus coeruleus
Marcus Grueschow, Nico Stenz, Hanna Thörn, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 77
Treatment of military-related post-traumatic stress disorder: challenges, innovations, and the way forward
David Forbes, David Pedlar, Amy B. Adler, et al.
International Review of Psychiatry (2019) Vol. 31, Iss. 1, pp. 95-110
Open Access | Times Cited: 76
Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial
Chadi G. Abdallah, John D. Roache, Ralitza Gueorguieva, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 8, pp. 1574-1581
Open Access | Times Cited: 64
Post-traumatic Stress Disorder
Addie N. Merians, Tobias R. Spiller, Ilan Harpaz‐Rotem, et al.
Medical Clinics of North America (2022) Vol. 107, Iss. 1, pp. 85-99
Closed Access | Times Cited: 47
Enhancing exposure therapy for posttraumatic stress disorder (PTSD): a randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer
JoAnn Difede, Barbara O. Rothbaum, Albert Rizzo, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top